Florida Senate - 2019                        COMMITTEE AMENDMENT
       Bill No. SB 630
                              LEGISLATIVE ACTION                        
                    Senate             .             House              

       The Committee on Health Policy (Perry) recommended the
    1         Senate Amendment (with title amendment)
    3         Delete everything after the enacting clause
    4  and insert:
    5         Section 1. Subsection (7) is added to section 456.44,
    6  Florida Statutes, to read:
    7         456.44 Controlled substance prescribing.—
    9         (a)The Legislature finds that every competent adult has
   10  the fundamental right of self-determination regarding decisions
   11  pertaining to his or her own health, including the right to
   12  refuse an opioid drug listed as a Schedule II controlled
   13  substance in s. 893.03 or 21 U.S.C. s. 812.
   14         (b)The department shall develop and publish on its website
   15  an educational pamphlet regarding the use of nonopioid
   16  alternatives for the treatment of pain. The pamphlet must, at a
   17  minimum, include:
   18         1.Information on available nonopioid alternatives for the
   19  treatment of pain, including nonopioid medicinal drugs or drug
   20  products and nonpharmacological therapies; and
   21         2.The advantages and disadvantages of the use of nonopioid
   22  alternatives.
   23         (c)Except in the provision of emergency services and care,
   24  as defined in s. 395.002, before providing medical treatment or
   25  anesthesia or prescribing an opioid drug listed as a Schedule II
   26  controlled substance in s. 893.03 or 21 U.S.C. s. 812 for the
   27  treatment of pain, a health care practitioner shall:
   28         1.Inform the patient of available nonopioid alternatives
   29  for the treatment of pain, which may include nonopioid medicinal
   30  drugs or drug products, acupuncture, chiropractic treatments,
   31  massage therapy, physical therapy, occupational therapy, or any
   32  other appropriate therapy as determined by the health care
   33  practitioner;
   34         2.Discuss the advantages and disadvantages of the use of
   35  nonopioid alternatives, including whether the patient is at a
   36  high risk of, or has a history of, controlled substance abuse or
   37  misuse and the patient’s personal preferences;
   38         3.Provide the patient with the educational pamphlet
   39  described in paragraph (b); and
   40         4.Document the nonopioid alternatives considered in the
   41  patient’s record.
   42         Section 2. This act shall take effect July 1, 2019.
   44  ================= T I T L E  A M E N D M E N T ================
   45  And the title is amended as follows:
   46         Delete everything before the enacting clause
   47  and insert:
   48                        A bill to be entitled                      
   49         An act relating to nonopioid alternatives; amending s.
   50         456.44, F.S.; providing a legislative finding;
   51         requiring the Department of Health to develop and
   52         publish on its website an educational pamphlet
   53         regarding the use of nonopioid alternatives for the
   54         treatment of pain; requiring that the pamphlet include
   55         specified information, including the advantages and
   56         disadvantages of the use of such alternatives;
   57         providing requirements for health care practitioners;
   58         providing an exception; providing an effective date.